Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,741,893
-$512,127 QoQ
Shares Held
46,233
-5.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#417
of 3,139 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGAR LOMAX CO/VA holds $161,967,278 across 7 Drug Manufacturers - General names. AMGN ranks #6 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
1,365,777 | $32,887,910 | |
| 2 | JNJ |
Johnson & Johnson
|
125,880 | $31,969,743 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
461,275 | $26,578,665 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
147,640 | $18,652,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
143,985 | $18,502,072 | |
| 6 | AMGN |
Amgen Inc
This page
|
46,233 | $16,741,893 | |
| 7 | ABBV |
AbbVie Inc.
|
66,103 | $16,634,158 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,741,893 | 46,233 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $17,254,020 | 49,038 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $32,074,743 | 97,995 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,307,482 | 100,310 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,372,686 | 130,270 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $41,244,546 | 132,385 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,930,081 | 141,690 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $46,548,067 | 144,465 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,841,101 | 146,715 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $42,249,952 | 148,600 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $65,095,688 | 226,011 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $63,262,341 | 235,386 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $54,170,881 | 243,991 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $59,802,906 | 247,375 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $57,239,761 | 217,940 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $49,391,902 | 219,130 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $53,882,434 | 221,465 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $52,123,091 | 215,545 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $31,419,310 | 139,660 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,966,638 | 140,920 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $34,684,406 | 142,295 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $37,114,987 | 149,170 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||